Financial News
Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
March 24, 2023 at 10:03 AM EDT
People who took Pfizer's antiviral treatment Paxlovid shortly after infection saw a 26% lower risk of long Covid compared with those who didn't, the study said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
